Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Abstract
Middle meningeal artery embolization facilitates resolution and prevents reaccumulation of chronic subdural hematoma and is more effective than conventional treatment without increasing treatment-related complications.
Purpose
To evaluate the effect of middle meningeal artery (MMA) embolization on chronic subdural hematoma (CSDH) and compare the treatment outcomes of MMA embolization and conventional treatment.
Materials and Methods
All consecutive patients 20 years or older with CSDH were assessed for eligibility. CSDHs with a focal location, a thickness of 10 mm or less, no mass effect, or underlying conditions were excluded. Seventy-two prospectively enrolled patients with CSDH underwent MMA embolization (embolization group; as the sole treatment in 27 [37.5%] asymptomatic patients and with additional hematoma removal for symptom relief in 45 [62.5%] symptomatic patients). For comparison, 469 patients who underwent conventional treatment were included as a historical control group (conventional treatment group; close, nonsurgical follow-up in 67 [14.3%] and hematoma removal in 402 [85.7%] patients). Primary outcome was treatment failure defined as a composite of incomplete hematoma resolution (remaining or reaccumulated hematoma with thickness > 10 mm) or surgical rescue (hematoma removal for relief of symptoms that developed with continuous growth of initial or reaccumulated hematoma). Secondary outcomes included surgical rescue as a component of the primary outcome and treatment-related complication for safety measure. Six-month outcomes were compared between the study groups with logistic regression analysis.
Results
Spontaneous hematoma resolution was achieved in all of 27 asymptomatic patients undergoing embolization without direct hematoma removal. Hematoma reaccumulation occurred in one (2.2%) of 45 symptomatic patients receiving embolization with additional hematoma removal. Treatment failure rate in the embolization group was lower than in the conventional treatment group (one of 72 patients [1.4%] vs 129 of 469 patients [27.5%], respectively; adjusted odds ratio [OR], 0.056; 95% confidence interval [CI]: 0.011, 0.286; P = .001). Surgical rescue was less frequent in the embolization group (one of 72 patients [1.4%] vs 88 of 469 patients [18.8%]; adjusted OR, 0.094; 95% CI: 0.018, 0.488; P = .005). Treatment-related complication rate was not different between the two groups (0 of 72 patients vs 20 of 469 patients [4.3%]; adjusted OR, 0.145; 95% CI: 0.009, 2.469; P = .182).
Conclusion
MMA embolization has a positive therapeutic effect on CSDH and is more effective than conventional treatment.
© RSNA, 2017
References
- 1. . The “subdural” space: a new look at an outdated concept. Neurosurgery 1993;32(1):111–120.
- 2. . Subdural compartment in pig: a morphologic study with blood and horseradish peroxidase infused subdurally. Anat Rec 1991;230(1):22–37.
- 3. . Working toward rational and evidence-based treatment of chronic subdural hematoma. Clin Neurosurg 2010;57:112–122.
- 4. . Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 2004;100(1):24–32.
- 5. . Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study. Inflamm Res 2012;61(8):845–852.
- 6. . Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma. J Neurosurg 1976;45(1):26–31.
- 7. . PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development. J Neurosurg 2013;118(2):353–357.
- 8. . The role of corticosteroids in the management of chronic subdural hematoma: a systematic review. Eur J Neurol 2012;19(11):1397–1403.
- 9. . Non-surgical primary treatment of chronic subdural haematoma: preliminary results of using dexamethasone. Br J Neurosurg 2005;19:327–33.
- 10. . Effects of atorvastatin on chronic subdural hematoma: a systemic review. Medicine (Baltimore) 2017;96(26):e7290.
- 11. . Perindopril and residual chronic subdural hematoma volumes six weeks after burr hole surgery: a randomized trial. Clin Neurol Neurosurg 2014;123:4–8.
- 12. . Nonsurgical treatment of chronic subdural hematoma with steroids. World Neurosurg 2015;84(6):1968–1972.
- 13. . The outer neomembrane of chronic subdural hematoma. Neurosurg Clin N Am 2000;11(3):407–412.
- 14. . Contents of chronic subdural hematoma. Neurosurg Clin N Am 2000;11(3):425–434.
- 15. . Histological study of operated cases of chronic subdural hematoma in adults: relationship between dura mater and outer membrane [in Japanese]. No Shinkei Geka 1997;25(8):701–705.
- 16. . Superselective angiographic findings of ipsilateral middle meningeal artery of chronic subdural hematoma in adults [in Japanese]. No Shinkei Geka 1998;26(4):339–347.
- 17. . Pathophysiology of evolution and recurrence of chronic subdural hematoma. Neurosurg Clin N Am 2000;11(3):435–438.
- 18. . How do vessels proliferate in the capsule of a chronic subdural hematoma? Neurosurgery 1984;15(5):672–678.
- 19. . Usefulness of embolization of the middle meningeal artery for refractory chronic subdural hematomas. Surg Neurol Int 2013;4:104.
- 20. . Embolization of the middle meningeal artery for refractory chronic subdural haematoma: usefulness for patients under anticoagulant therapy. Interv Neuroradiol 2004;10(Suppl 2):101–104.
- 21. . Experience in endovascular treatment of recurrent chronic subdural hematoma. Interv Neuroradiol 2007;13(suppl 1):141–144.
- 22. . Middle meningeal artery embolization in recurrent chronic subdural hematoma combined with arachnoid cyst. Korean J Neurotrauma 2015;11(2):187–190.
- 23. . Middle meningeal artery embolization for refractory chronic subdural hematoma: case report. J Neurosurg 2000;93(4):686–688.
- 24. . Efficacy of middle meningeal artery embolization in the treatment of refractory chronic subdural hematoma. Surg Neurol Int 2010;1:78.
- 25. . Middle meningeal artery embolization for refractory chronic subdural hematoma: 3 case reports [in Japanese]. No Shinkei Geka 2002;30(5):535–539.
- 26. . Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: five cases and a review of the literature. Interv Neuroradiol 2015;21(3):366–371.
- 27. . Transarterial embolisation for refractory bilateral chronic subdural hematomas in a case with dentatorubral-pallidoluysian atrophy. Acta Neurochir (Wien) 2011;153(5):1145–1147.
- 28. . Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 2001;95(2):256–262.
- 29. . Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo) 2001;41(8):382–386.
- 30. . Efficacy and safety of subdural drains after burr-hole evacuation of chronic subdural hematomas: systematic review and meta-analysis of randomized controlled trials. World Neurosurg 2014;82(6):1148–1157.
- 31. . Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg 2014;121(3):665–673.
- 32. . Analysis and reporting of factorial trials: a systematic review. JAMA 2003;289(19):2545–2553.
Article History
Received January 7, 2017; revision requested March 6; revision received June 19; accepted July 15; final version accepted August 14.Published online: Oct 10 2017
Published in print: Mar 2018